Cervical Cancer Screening in HIV-Positive Individuals

HIV-Specific Screening Guidelines Override General Population Recommendations

The Infectious Disease Society of America (IDSA) and US Public Health Service (USPHS) guidelines recommend that women who are HIV-positive should be tested twice during the first year after diagnosis, and annually thereafter, regardless of age or CD4 count 1, 2
Individuals with HIV are explicitly excluded from standard cervical cancer screening guidelines and require more intensive surveillance, according to the American family physician guidelines 3, 4

The US Public Health Service (USPHS) and Infectious Disease Society of America (IDSA) guidelines state that all HIV-positive individuals with a cervix should undergo annual screening, regardless of CD4 count 1, 2
HIV infection confers immunocompromised status, placing patients at substantially higher risk for HPV persistence and progression to cervical dysplasia, as stated by the Ca-A Cancer Journal for Clinicians 1, 2

The USPSTF guidelines explicitly state that their recommendations "do not apply to individuals with a compromised immune system (e.g., women living with HIV)", and HIV-positive patients should have their first Pap smear at HIV diagnosis or shortly thereafter, followed by annual screening indefinitely 1, 2, 3, 4
There is no specific age to stop screening for HIV-positive patients, and screening should continue for as long as they are in reasonably good health and would benefit from early detection and treatment, according to the Ca-A Cancer Journal for Clinicians 1, 2

The USPSTF and American Cancer Society guidelines explicitly exclude immunocompromised patients, including those with HIV, and people with HIV require earlier and more intensive screening than the general population, starting at age 21-25, due to their significantly elevated risk of HPV persistence and progression to cervical dysplasia 5, 6, 7, 8
HIV-positive individuals require individualized follow-up due to their substantially increased cervical cancer risk 5, 6, 7, 8

The Centers for Disease Control and Prevention recommends that individuals with HIV should begin cervical cancer screening at age 21 years or 1 year after onset of sexual activity, but no later than age 21 years 9, 10
The Centers for Disease Control and Prevention suggests that screening must begin 1 year after sexual debut in adolescents with HIV, regardless of age or mode of HIV acquisition, but no later than age 21 years 9, 10
The Centers for Disease Control and Prevention indicates that adolescents with HIV demonstrate a high rate of progression of abnormal cytology, unlike immunocompetent adolescents, warranting earlier screening 9, 10

The Centers for Disease Control and Prevention recommends using conventional or liquid-based cytology as the primary screening method, and primary HPV testing alone is not recommended in individuals with HIV 9, 10
The Centers for Disease Control and Prevention suggests that cotesting can be performed in individuals aged 30 years or older with HIV 9, 10

The Centers for Disease Control and Prevention recommends annual screening for all persons with HIV infection 9, 10
The Centers for Disease Control and Prevention indicates that after 3 consecutive years of normal cytology results or normal cotests, the screening interval can be extended to every 3 years 9, 10
The Centers for Disease Control and Prevention recommends lifelong screening among persons with HIV infection, with no age at which to discontinue screening 9, 10

The Centers for Disease Control and Prevention advises against using primary HPV testing alone in people with HIV, as cytology should be the primary screening method 9, 10
The Centers for Disease Control and Prevention recommends against discontinuing screening at age 65 in people with HIV, as lifelong screening is indicated 9, 10
The Centers for Disease Control and Prevention suggests against delaying screening until age 21 if sexual activity began earlier in adolescents with HIV, and instead recommends screening 1 year after sexual debut 9, 10